DE ROSE, Virginia
 Distribuzione geografica
Continente #
NA - Nord America 2.890
EU - Europa 2.389
AS - Asia 1.360
SA - Sud America 66
OC - Oceania 53
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.787
Nazione #
US - Stati Uniti d'America 2.690
CN - Cina 728
IT - Italia 360
FR - Francia 300
GB - Regno Unito 281
DE - Germania 276
IE - Irlanda 273
UA - Ucraina 204
JP - Giappone 201
FI - Finlandia 170
SE - Svezia 162
CA - Canada 160
KR - Corea 148
SG - Singapore 104
DK - Danimarca 81
PL - Polonia 69
AU - Australia 53
BE - Belgio 50
TR - Turchia 47
ES - Italia 44
VN - Vietnam 39
BR - Brasile 33
MX - Messico 33
IN - India 32
CH - Svizzera 20
NL - Olanda 18
SN - Senegal 18
RU - Federazione Russa 16
PT - Portogallo 14
GR - Grecia 13
HK - Hong Kong 12
PE - Perù 11
AT - Austria 10
CZ - Repubblica Ceca 9
TW - Taiwan 9
CL - Cile 8
SA - Arabia Saudita 8
ID - Indonesia 7
IL - Israele 6
IR - Iran 6
PR - Porto Rico 6
AR - Argentina 5
CO - Colombia 5
EC - Ecuador 4
MY - Malesia 4
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
IQ - Iraq 2
LV - Lettonia 2
MA - Marocco 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
LK - Sri Lanka 1
NG - Nigeria 1
RS - Serbia 1
TH - Thailandia 1
Totale 6.787
Città #
Beijing 365
Chandler 344
Ann Arbor 290
Dublin 267
Jacksonville 136
Villeurbanne 112
Hangzhou 111
Redwood City 105
Princeton 98
Medford 96
Houston 81
Fairfield 80
Wilmington 76
Ashburn 73
Dearborn 71
Singapore 69
Milan 64
Torino 56
Nyköping 54
Seattle 54
Warsaw 52
Toronto 47
New York 39
Woodbridge 39
Verona 38
Boston 35
Dong Ket 28
Guangzhou 25
Fremont 24
Cambridge 22
Lappeenranta 21
Boardman 20
Brussels 20
Shanghai 20
Pisa 19
Falls Church 18
Nantes 16
Norwalk 16
Hefei 15
Lachine 15
Nanchang 15
Turin 15
Rome 14
Montreal 13
Granada 12
Shenyang 12
Belfast 11
Madison 11
Montréal 11
Munich 10
Nanjing 10
Paris 10
London 9
Pune 9
Cardiff 8
Duncan 8
Hebei 8
Vienna 8
Birmingham 7
Jakarta 7
Jinan 7
Manchester 7
Zhengzhou 7
Auburn Hills 6
Bornem 6
Hong Kong 6
Ilgın 6
Istanbul 6
Kansas City 6
Newcastle upon Tyne 6
Ottawa 6
Poitiers 6
Santa Cruz 6
Tokyo 6
Washington 6
Belvedere Spinello 5
Bristol 5
Central District 5
Chicago 5
Chongqing 5
Denver 5
Frankfurt am Main 5
Hamilton 5
Iowa City 5
Lima 5
Madrid 5
Melbourne 5
Mississauga 5
Nottingham 5
Porto Alegre 5
Riyadh 5
San Diego 5
Santiago 5
Sydney 5
Trujillo 5
Aguadilla 4
Austin 4
Catania 4
Chengdu 4
Cincinnati 4
Totale 3.552
Nome #
CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease 1.755
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial 356
Genetic deletion and pharmacological inhibition of PI3K γ reduces neutrophilic airway inflammation and lung damage in mice with cystic fibrosis-like lung disease 313
Bradykinin- and lipopolysaccharide-induced bradykinin B(2) receptor expression, interleukin 8 release and "nitrosative stress" in bronchial epithelial cells BEAS-2B: Role for neutrophils. 286
Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD 175
The guinea pig as an animal model for asthma 130
Airway Epithelium Dysfunction in Cystic Fibrosis and COPD 124
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 106
Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis 96
Clinical guidelines and indications for bronchoalveolar lavage (BAL): chronic bronchitis and emphysema. 94
Clinical guidelines and indications for bronchoalveolar lavage (BAL): bronchial asthma. 87
Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches 85
Adhesion receptor expression on peripheral blood T lymphocyte subsets after specific inhalation challenge. 82
[Usefulness of chest X-ray during cystic fibrosis exacerbation in adult patients] 81
[Efficacy and tolerability of imipenem/cilastatin in infections at various sites] 80
[Clinical and pharmacokinetic study of ciprofloxacin at the level of the respiratory system] 79
[Effect of clofoctol on various parameters of phagocyte function] 78
[Effect of glycopeptide antibiotics on human phagocyte activity] 74
[Study of aspecific bronchial reactivity in subjects with allergic diseases and in bronchial asthma patients] 74
The clinical role of BAL in idiopathic pulmonary fibrosis. 72
Evaluation of the host defense system in asthmatic patients. 71
Evaluation of systemic host defense mechanisms in chronic bronchitis. 71
Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? 71
Roxithromycin (RU 28965) in the treatment of respiratory tract infections. 68
[Use of aztreonam in the treatment of respiratory infections] 68
Double-blind trial RU 41740 vs. placebo: immunological and clinical effects in a group of patients with chronic bronchitis. 68
Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis 68
IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis 65
Cyclin D1 blockade as a limiting factor of the granulomatous response in tuberculosis. 65
[In vitro and ex vivo effect of antimicrobial agents on the chemotaxis of human neutrophils] 63
Proteomic analysis of sputum from adults with cystic fibrosis and COPD:identification of potential biomakers for disease monitoring. 60
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. 59
Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis. 58
Circulating adhesion molecules in cystic fibrosis. 57
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. 57
Patterns of response to allergen challenge. 57
CD8-positivity is not associated with IL4 and IL5 gene expression in chronic bronchitis. 56
Mechanisms and markers of airway inflammation in cystic fibrosis 55
In vivo study of xibornol on phagocyte functions. 55
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 55
Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease 55
[Function of the defense system in patients with primary neoplasms of the lung. Preliminary results] 54
The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms. 54
Malattie respiratorie croniche ostruttive 53
Circulating adhesion molecules in patients with cystic fibrosis. 53
Increased numbers of airway wall plasma cells in smokers with chronic bronchitis: co-localization and gene expression for interleukin 4 and 5. 52
Lung immunoglobulin A immunity dysregulation in cystic fibrosis. 52
Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease. 51
[Pharmacokinetics of cofosfolactamines in subjects with impaired kidney function] 50
Interstitial pneumopathy and low-dosage amiodarone. 46
Influence of ceftriaxone on natural defense systems. 46
Inflammatory cytokines in airways secretions from patients with cystic fibrosis upregulate endothelial adhesion molecules in vitro. 46
Intercellular adhesion molecule-1 is upregulated on peripheral blood T lymphocyte subsets in dual asthmatic responders. 46
Increased numbers of airway mast cells in chronic bronchitis: localization and gene expression for interleukin 4,5 and TNF-alpha. 45
Relationship between total inflammatory cell number and lung function in large and small airways. 43
Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis. 41
Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis. 41
"In vitro" effect of non steroidal antiinflammatory agents on mononuclear phagocyte functions. 41
STRATEGIES IN THE PHARMACOLOGIC PREVENTION OF LUNG EMPHYSEMA. 40
Penetration of roxithromycin in bronchial secretions. 40
Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis 40
Metabolism of arachidonic acid in human alveolar macrophages from patients with sarcoidosis. 39
Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells. 37
Substance P increases neutrophil adhesion to bronchial epithelial cells 37
Variation in CD8+ T cell counts in the bronchial wall of subjects with chronic bronchitis. 37
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate 37
Familial elevation of serum angiotensin converting enzyme activity. 36
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. 35
La semeiotica dell’Apparato Respiratorio 33
Substance P increases neutrophil adhesion to bronchial epithelial cells. 33
Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis 33
Elevation of serum type III procollagen N-terminal peptide levels in thoracic sarcoidosis: a possible index for fibroblast activity. 32
EPITHELIAL CELL ADHESION MOLECULES AND INFLAMMATORY CELL/EPITHELIAL CELL INTERACTIONS 32
IL-4 and IL-5 mRNA in the bronchial wall of smokers. 32
IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic asthmatic patients by inducing FAS/FASL-mediated apoptosis. 32
Inflammatory changes in large and small airways of patients with chronic obstructive pulmonary disease. 31
Mantle radiotherapy increases airway responsiveness. 31
Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease 28
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis 3
Totale 7.041
Categoria #
all - tutte 18.222
article - articoli 0
book - libri 0
conference - conferenze 2.619
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020856 0 0 0 95 94 104 113 62 135 73 100 80
2020/20211.030 110 50 74 66 115 66 85 47 137 114 53 113
2021/20221.162 61 66 52 78 111 90 99 74 51 65 165 250
2022/20231.228 152 84 56 84 105 298 130 90 107 30 59 33
2023/2024556 73 79 41 53 36 75 13 24 9 46 36 71
2024/2025118 16 38 47 17 0 0 0 0 0 0 0 0
Totale 7.041